Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 9—September 2013

Acute Encephalitis Syndrome Surveillance, Kushinagar District, Uttar Pradesh, India, 2011–2012

Manish KakkarComments to Author , Elizabeth T. Rogawski, Syed Shahid Abbas, Sanjay Chaturvedi, Tapan N. Dhole, Shaikh Shah Hossain, and Sampath K. Krishnan
Author affiliations: Public Health Foundation of India, New Delhi, India (M. Kakkar, E.T. Rogawski, S.S. Abbas); University College of Medical Sciences, New Delhi (S. Chaturvedi); Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India (T.N. Dhole); Centers for Disease Control and Prevention, New Delhi (S.S. Hossain); Office of the World Health Organization Representative to India, New Delhi (S.K. Krishnan)

Main Article

Table 2

Incidence of acute encephalitis syndrome, Kushinagar District, Uttar Pradesh, India, 2011–2012*

Age, sex of population 2011 population† No. cases Incidence‡ Incidence rate ratio (95% CI)
All ages 3,560,830 721 20.2
M 1,821,242 414 22.7 1.29 (1.11–1.49)
0–6 y 551,467 428 77.6
M 287,672 260 90.4 1.42 (1.17–1.72)
F 263,795 168 63.7 1.0

*Based on data obtained from Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India.
†From 2011 Census of India (20).
‡Per 100,000 population.

Main Article

  1. Directorate of National Vector Borne Diseases Control Programme. Guidelines for surveillance of acute encephalitis syndrome (with special reference to Japanese encephalitis) [cited 2012 Sept 27].
  2. Hills  S, Dabbagh  A, Jacobson  J, Marfin  A, Featherstone  D, Hombach  J, Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance. BMC Infect Dis. 2009;9:214. DOIPubMedGoogle Scholar
  3. World Health Organization. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: The Organization; 2008.
  4. National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare. Japanese encephalitis [cited 2012 Sept 27].
  5. Parida  M, Dash  PK, Tripathi  NK, Sannarangaiah  S, Saxena  P, Agarwal  S, Japanese encephalitis outbreak, India, 2005. Emerg Infect Dis. 2006;12:142730. DOIPubMedGoogle Scholar
  6. Roy  A, Tandon  R, Agarwal  SK, Banerjee  G. Seroprevalence of Japanese encephalitis virus infection in Lucknow, Uttar Pradesh. Indian J Med Res. 2006;124:2112.PubMedGoogle Scholar
  7. Kumar  R, Tripathi  P, Singh  S, Bannerji  G. Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India. Clin Infect Dis. 2006;43:12331. DOIPubMedGoogle Scholar
  8. Samuel  PP, Ayanar  K, Kannan  M, Thenmozhi  V, Paramasivan  R, Balasubramanian  A, Sero-entomological investigations on Japanese encephalitis outbreak in Gorakhpur Division, Uttar Pradesh, India. Indian J Med Res. 2009;129:32932.PubMedGoogle Scholar
  9. Arunachalam  N, Samuel  PP, Paramasivan  R, Balasubramanian  A, Tyagi  BK. Japanese encephalitis in Gorakhpur Division, Uttar Pradesh. Indian J Med Res. 2008;128:7757.PubMedGoogle Scholar
  10. Sarkari  NBS, Thacker  AK, Barthwal  SP, Mishra  VK, Prapann  S, Srivastava  D, Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol. 2012;259:4757. DOIPubMedGoogle Scholar
  11. Saxena  SK, Mishra  N, Saxena  R, Singh  M, Mathur  A. Trend of Japanese encephalitis in north India: evidence from thirty-eight acute encephalitis cases and appraisal of niceties. J Infect Dev Ctries. 2009;3:51730. DOIPubMedGoogle Scholar
  12. Immunization Division, Department of Family Welfare, Ministry of Health and Family Welfare, Government of India. Operational guide for Japanese encephalitis vaccination in India. New Delhi: The Ministry; 2007.
  13. Directorate of National Vector Borne Diseases Control Programme—Delhi. Details of AES/JE cases and deaths from 2008–2013 [cited 2013 Jan 20].
  14. Sapkal  GN, Bondre  VP, Fulmali  PV, Patil  P, Gopalkrishna  V, Dadhania  V, Enteroviruses in patients with acute encephalitis, Uttar Pradesh, India. Emerg Infect Dis. 2009;15:2958. DOIPubMedGoogle Scholar
  15. Lewthwaite  P, Perera  D, Ooi  MH, Last  A, Kumar  R, Desai  A, Enterovirus 75 encephalitis in children, southern India. Emerg Infect Dis. 2010;16:17802. DOIPubMedGoogle Scholar
  16. Karmarkar  SA, Aneja  S, Khare  S, Saini  A, Seth  A, Chauhan  BKY. A study of acute febrile encephalopathy with special reference to viral etiology. Indian J Pediatr. 2008;75:8015. DOIPubMedGoogle Scholar
  17. Bhatt  GC, Bondre  VP, Sapkal  GN, Sharma  T, Kumar  S, Gore  MM, Changing clinico-laboratory profile of encephalitis patients in the eastern Uttar Pradesh region of India. Trop Doct. 2012;42:1068. DOIPubMedGoogle Scholar
  18. Beig  FK, Malik  A, Rizvi  M, Acharya  D, Khare  S. Etiology and clinico-epidemiological profile of acute viral encephalitis in children of western Uttar Pradesh, India. Int J Infect Dis. 2010;14:e1416. DOIPubMedGoogle Scholar
  19. Planning Commission of India. Report of the Working Group on Disease Burden for the 12th Five Year Plan [cited 2013 Nov 3].
  20. Office of the Registrar General and Census Commissioner (India). India population and housing census 2011. New Delhi (India): The Office; 2011.
  21. German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50(RR-13):1–35.PubMedGoogle Scholar
  22. UNICEF. Japanese encephalitis coverage evaluation survey report 2008 [cited 2012 Oct 8].
  23. Press Information Bureau, Government of India. Implementation of intervention/activities for prevention and control of Japanese encephalitis (JE)/acute encephalitis syndrome (AES). 2012 [cited 2012 Nov 3].

Main Article

Page created: July 29, 2013
Page updated: August 20, 2013
Page reviewed: August 20, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.